Potentially commercializable nerve guidance conduits for peripheral nerve injury: Past, present, and future

Peripheral nerve injuries are a prevalent global issue that has garnered great concern. Although autografts remain the preferred clinical approach to repair, their efficacy is hampered by factors like donor scarcity. The emergence of nerve guidance conduits as novel tissue engineering tools offers a...

Full description

Saved in:
Bibliographic Details
Main Authors: Chundi Liu, Mouyuan Sun, Lining Lin, Yaxian Luo, Lianjie Peng, Jingyu Zhang, Tao Qiu, Zhichao Liu, Jun Yin, Mengfei Yu
Format: Article
Language:English
Published: Elsevier 2025-04-01
Series:Materials Today Bio
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2590006425000614
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823859394588180480
author Chundi Liu
Mouyuan Sun
Lining Lin
Yaxian Luo
Lianjie Peng
Jingyu Zhang
Tao Qiu
Zhichao Liu
Jun Yin
Mengfei Yu
author_facet Chundi Liu
Mouyuan Sun
Lining Lin
Yaxian Luo
Lianjie Peng
Jingyu Zhang
Tao Qiu
Zhichao Liu
Jun Yin
Mengfei Yu
author_sort Chundi Liu
collection DOAJ
description Peripheral nerve injuries are a prevalent global issue that has garnered great concern. Although autografts remain the preferred clinical approach to repair, their efficacy is hampered by factors like donor scarcity. The emergence of nerve guidance conduits as novel tissue engineering tools offers a promising alternative strategy. This review aims to interpret nerve guidance conduits and their commercialization from both clinical and laboratory perspectives. To enhance comprehension of clinical situations, this article provides a comprehensive analysis of the clinical efficacy of nerve conduits approved by the United States Food and Drug Administration. It proposes that the initial six months post-transplantation is a critical window period for evaluating their efficacy. Additionally, this study conducts a systematic discussion on the research progress of laboratory conduits, focusing on biomaterials and add-on strategies as pivotal factors for nerve regeneration, as supported by the literature analysis. The clinical conduit materials and prospective optimal materials are thoroughly discussed. The add-on strategies, together with their distinct obstacles and potentials are deeply analyzed. Based on the above evaluations, the development path and manufacturing strategy for the commercialization of nerve guidance conduits are envisioned. The critical conclusion promoting commercialization is summarized as follows: 1) The optimization of biomaterials is the fundamental means; 2) The phased application of additional strategies is the emphasized direction; 3) The additive manufacturing techniques are the necessary tools. As a result, the findings of this research provide academic and clinical practitioners with valuable insights that may facilitate future commercialization endeavors of nerve guidance conduits.
format Article
id doaj-art-54226e80c0494e5fbe89e8b5b1fee1b3
institution Kabale University
issn 2590-0064
language English
publishDate 2025-04-01
publisher Elsevier
record_format Article
series Materials Today Bio
spelling doaj-art-54226e80c0494e5fbe89e8b5b1fee1b32025-02-11T04:35:21ZengElsevierMaterials Today Bio2590-00642025-04-0131101503Potentially commercializable nerve guidance conduits for peripheral nerve injury: Past, present, and futureChundi Liu0Mouyuan Sun1Lining Lin2Yaxian Luo3Lianjie Peng4Jingyu Zhang5Tao Qiu6Zhichao Liu7Jun Yin8Mengfei Yu9Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Engineering Research Center of Oral Biomaterials and Devices of Zhejiang Province, Hangzhou, 310000, ChinaStomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Engineering Research Center of Oral Biomaterials and Devices of Zhejiang Province, Hangzhou, 310000, China; Corresponding author.Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Engineering Research Center of Oral Biomaterials and Devices of Zhejiang Province, Hangzhou, 310000, ChinaStomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Engineering Research Center of Oral Biomaterials and Devices of Zhejiang Province, Hangzhou, 310000, ChinaStomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Engineering Research Center of Oral Biomaterials and Devices of Zhejiang Province, Hangzhou, 310000, ChinaStomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Engineering Research Center of Oral Biomaterials and Devices of Zhejiang Province, Hangzhou, 310000, ChinaStomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Engineering Research Center of Oral Biomaterials and Devices of Zhejiang Province, Hangzhou, 310000, ChinaStomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Engineering Research Center of Oral Biomaterials and Devices of Zhejiang Province, Hangzhou, 310000, ChinaThe State Key Laboratory of Fluid Power and Mechatronic Systems, Key Laboratory of 3D Printing Process and Equipment of Zhejiang Province, School of Mechanical Engineering, Zhejiang University, Hangzhou, 310027, China; Corresponding author.Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Engineering Research Center of Oral Biomaterials and Devices of Zhejiang Province, Hangzhou, 310000, China; Corresponding author.Peripheral nerve injuries are a prevalent global issue that has garnered great concern. Although autografts remain the preferred clinical approach to repair, their efficacy is hampered by factors like donor scarcity. The emergence of nerve guidance conduits as novel tissue engineering tools offers a promising alternative strategy. This review aims to interpret nerve guidance conduits and their commercialization from both clinical and laboratory perspectives. To enhance comprehension of clinical situations, this article provides a comprehensive analysis of the clinical efficacy of nerve conduits approved by the United States Food and Drug Administration. It proposes that the initial six months post-transplantation is a critical window period for evaluating their efficacy. Additionally, this study conducts a systematic discussion on the research progress of laboratory conduits, focusing on biomaterials and add-on strategies as pivotal factors for nerve regeneration, as supported by the literature analysis. The clinical conduit materials and prospective optimal materials are thoroughly discussed. The add-on strategies, together with their distinct obstacles and potentials are deeply analyzed. Based on the above evaluations, the development path and manufacturing strategy for the commercialization of nerve guidance conduits are envisioned. The critical conclusion promoting commercialization is summarized as follows: 1) The optimization of biomaterials is the fundamental means; 2) The phased application of additional strategies is the emphasized direction; 3) The additive manufacturing techniques are the necessary tools. As a result, the findings of this research provide academic and clinical practitioners with valuable insights that may facilitate future commercialization endeavors of nerve guidance conduits.http://www.sciencedirect.com/science/article/pii/S2590006425000614Nerve guidance conduitPeripheral nerveClinical efficacyBiomaterialAdd-on strategy
spellingShingle Chundi Liu
Mouyuan Sun
Lining Lin
Yaxian Luo
Lianjie Peng
Jingyu Zhang
Tao Qiu
Zhichao Liu
Jun Yin
Mengfei Yu
Potentially commercializable nerve guidance conduits for peripheral nerve injury: Past, present, and future
Materials Today Bio
Nerve guidance conduit
Peripheral nerve
Clinical efficacy
Biomaterial
Add-on strategy
title Potentially commercializable nerve guidance conduits for peripheral nerve injury: Past, present, and future
title_full Potentially commercializable nerve guidance conduits for peripheral nerve injury: Past, present, and future
title_fullStr Potentially commercializable nerve guidance conduits for peripheral nerve injury: Past, present, and future
title_full_unstemmed Potentially commercializable nerve guidance conduits for peripheral nerve injury: Past, present, and future
title_short Potentially commercializable nerve guidance conduits for peripheral nerve injury: Past, present, and future
title_sort potentially commercializable nerve guidance conduits for peripheral nerve injury past present and future
topic Nerve guidance conduit
Peripheral nerve
Clinical efficacy
Biomaterial
Add-on strategy
url http://www.sciencedirect.com/science/article/pii/S2590006425000614
work_keys_str_mv AT chundiliu potentiallycommercializablenerveguidanceconduitsforperipheralnerveinjurypastpresentandfuture
AT mouyuansun potentiallycommercializablenerveguidanceconduitsforperipheralnerveinjurypastpresentandfuture
AT lininglin potentiallycommercializablenerveguidanceconduitsforperipheralnerveinjurypastpresentandfuture
AT yaxianluo potentiallycommercializablenerveguidanceconduitsforperipheralnerveinjurypastpresentandfuture
AT lianjiepeng potentiallycommercializablenerveguidanceconduitsforperipheralnerveinjurypastpresentandfuture
AT jingyuzhang potentiallycommercializablenerveguidanceconduitsforperipheralnerveinjurypastpresentandfuture
AT taoqiu potentiallycommercializablenerveguidanceconduitsforperipheralnerveinjurypastpresentandfuture
AT zhichaoliu potentiallycommercializablenerveguidanceconduitsforperipheralnerveinjurypastpresentandfuture
AT junyin potentiallycommercializablenerveguidanceconduitsforperipheralnerveinjurypastpresentandfuture
AT mengfeiyu potentiallycommercializablenerveguidanceconduitsforperipheralnerveinjurypastpresentandfuture